Alterity Therapeutics Limited (ASX:ATH)
Australia · Delayed Price · Currency is AUD 0.2650
+0.0100 (3.92%)
Oct 22, 2026, 4:10 PM AEDT
Alterity Therapeutics Market Cap
Alterity Therapeutics has a market cap or net worth of 60.71 million as of October 22, 2026. It is the 31,517th most valuable company in the world and the 731st biggest in Australia. Its market cap has decreased by 53.48% in one year.
Market Cap
60.71M
Enterprise Value
23.59M
Revenue
3.61M
Global Rank
Country Rank
#731 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since March 28, 2000, Alterity Therapeutics's market cap has increased from 51.51M to 60.71M, an increase of 17.86%. That is a compound annual growth rate of 0.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 60.71M | -30.22% |
| Dec 31, 2025 | 87.00M | 104.41% |
| Dec 31, 2024 | 42.56M | 116.97% |
| Dec 29, 2023 | 19.62M | -18.82% |
| Dec 30, 2022 | 24.16M | -52.19% |
| Dec 31, 2021 | 50.54M | -19.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Recce Pharmaceuticals | 108.55M |
| Island Pharmaceuticals | 100.67M |
| LTR Pharma | 88.40M |
| Avecho Biotechnology | 65.68M |
| Prescient Therapeutics | 65.20M |
| Arovella Therapeutics | 61.65M |
| Neurizon Therapeutics | 59.68M |
| Entropy Neurodynamics | 52.28M |